Last reviewed · How we verify
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
This is a study using a parallel control approach and is expected to recruit 35 volunteers, including 8 prostate cancer patients, 8 neuroendocrine tumour patients, 8 glioma patients, 8 Parkinson's syndrome patients, and 3 normal volunteers, to undergo dual-nuclide PET/CT imaging and to validate the isolation effect and quantitative accuracy of simultaneous dual-nuclide imaging in humans.
Details
| Lead sponsor | Xijing Hospital |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 35 |
| Start date | Fri Mar 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Mar 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Prostatic Neoplasms
- Glioma
- PARKINSON DISEASE (Disorder)
Interventions
- PET/CT
Countries
China